|
|
||||||||
William Beaumont Army Medical Center, El Paso, Texas
Correspondence: For reprints contact: Douglas L. Daniels, Nuclear Medicine Service, William Beaumont Army Medical Center, El Paso, TX 79920.
ABSTRACT
Of 5008 patients with normal serum thyroxine concentrations (T4 = 4.812.2 µg/dl) assayed by our laboratory during an 11-mo period, only 41 (0.82%) had an abnormal free thyroxine index (FTI). Narrowing the T4 normal range by 0.5 µg/dl at both ends to create a discriminatory range of 5.311.7 µg/dl reduced this number to 13( 0.26%). Evaluation of the medical records for 11 of these 13 patients revealed histories of estrogen and thyroid-hormone administration, individually or in combination, which may have contributed to their divergence from the population. A program for the selective performance of serum T3 uptake (T3U) and FTI determinations only on those sera with T4 concentrations outside of a discriminatory range is described and evaluated. This initial discrimination is the first step in a practical system for selective performance of additional in vitro thyroid function assays to derive maximum diagnostic information from a single patient sample. In our institution the program described is easily adapted to computerization and has resulted in a substantial reduction of reagent costs while providing more efficient utilization of laboratory personnel.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |